Heron Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 0.2944 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 55.89M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emeto...